leisure time -WSS

leisure time

author：hotspot 2025-09-28 01:38:09 - browse：9

Dr. Peter Bach — Peter Bach, shown at the 2019 STAT summit, is now chief medical officer of Delfi. Emilie Pickering for STAT

Delfi Diagnostics, a well-funded startup in the burgeoning field of creating blood tests to detect cancer, said on Monday that it is launching a new test, FirstLook Lung, to try to identify people who could most benefit from lung cancer screening.

The approach represents a new one in the field of liquid biopsy, in which DNA fragments in blood are used to detect or learn about tumors. Grail, another company developing a blood test for cancer screening, has insisted that its product would be best used to detect multiple cancers at once. Other companies, including Exact Sciences and Freenome, are developing tests that would focus on detecting colorectal cancer. But Delfi appears to be the first to focus first on lung cancer, the leading cause of cancer death.

Delfi’s executives, in an interview with STAT, were clear that they view the initial launch as an opportunity to gather information, and not a real commercial coming out. The test will likely become available in limited ways with specific partners and will not initially be covered by insurance. Delfi declined to reveal a specific price, but said that its early access customers, which it is not yet disclosing, will be able to use FirstLook Lung for several hundred dollars. Such a rollout does not require approval from the Food and Drug Administration, which Delfi does not have.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： A common UTI test for kids haunts adults as a traumatic 'nightmare'

hotspot

focus

WSS

Popular nasal decongestant doesn't actually relieve congestion

Jack Smith previously got search warrant for Trump's Twitter, new court docs show

Police still searching for prisoner who escaped from NYC hospital

Diverse clinical trials: Why aren’t we there yet?

White House touts steps to stem shortages of cancer treatments

FDA approves updated Covid vaccines

explore

leisure time

leisure time

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Generate Biomedicines machine learning biotech raises $273M

Anesthesiologist group: stop taking Ozempic before surgery

Why failed clinical trials don’t always spell doom for a new drug

The cancer drug shortage isn’t new — and neither are the solutions

Pig kidney works a record two months in donated body

In Memoriam: Notable people who died in 2023

WATCH: Why do bright lights make us see spots?

How one medical school became remarkably diverse

PEPFAR is under serious threat — and so is global health

hotspot

The best solution to the drug shortages problem

Wayne Brady comes out as pansexual: 'Free to love whomever I want'

Walmart eyes Medicare Advantage provider ChenMed

WATCH: Why do bright lights make us see spots?

Friends ask where James Watson's attitudes about race came from

American woman, child freed after being kidnapped in Haiti last month

hotspot

hotspot

focus

hotspot